Influence of respiratory tract infections on cardiopulmonary performance of Amateur and professional athletes - a pilot study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00028486

Enrollment

100

Registered

2022-07-27

Start date

2022-10-01

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J06.9

Interventions

Group 1: 100 athletes from regular care who are recalled after a respiratory infection A smear test is performed as part of the infection The smear test and virological testing are performed accordin

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Symptomatic respiratory tract infection - Negative SARS-CoV-2 test before spiroergometry. - Age =18 years. - Regular exercise activity with participation in competitions

Exclusion criteria

Exclusion criteria: - Known underlying pulmonary or cardiac disease defined as heart failure with preserved or reduced pump function, myocarditis, known coronary artery disease, obstructive restrictive lung disease - Positive SARS-COV-2 test after clinical symptoms. - Lack of consent - Pregnancy - Age<18 yrs.

Design outcomes

Primary

Measure	Time frame
Change in spiroergometric parameters, especially VO2max, O2 pulse, maximum power in W	—

Secondary

Measure	Time frame
Cardiac enzymes, blood cell count, NLRP3 inflammasome, inflammatory parameters.	—

Countries

Germany

Contacts

Public ContactAlexander Kogel

Klinik und Poliklinik für Kardiologie

alexander.kogel@medizin.uni-leipzig.de03419712650

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026